Department of Epidemiology, School of Public Health, Zhejiang Chinese Medical University, No. 548, Binwen Rd, Hangzhou 310053, China.
Center for Disease Control and Prevention of Yinzhou District, Ningbo, Zhejiang 315100, China.
J Infect. 2021 Feb;82(2):253-260. doi: 10.1016/j.jinf.2020.12.013. Epub 2021 Jan 6.
Herpes zoster (HZ) mainly affects elderly and immunocompromised individuals and is characterized by a painful vesicular rash. Data on the epidemiology of HZ, particularly in unvaccinated individuals aged ≥50 years, are still limited in China. Thus, this study aimed to evaluate the epidemiological features, disease burden, and associated risk factors of HZ in the population aged ≥50 years in China.
We evaluated HZ patients who were aged ≥50 years between January 1, 2015 and December 31, 2017 in the electronic health record database of Yinzhou district. HZ and its complications were identified using ICD-10 codes. In addition, post-herpetic neuralgia (PHN) as a complication of HZ was defined as pain occurring or persisting 90 days after rash onset. The disease burden was estimated according to the duration of hospitalization, frequency of visits, pharmacological treatment cost, and examination cost. Cox proportional hazards regression was used to investigate the associated risk factors for HZ.
The overall incidence of HZ was 6.64 per 1000 person-years. Of the 4,313 initial episodes from 2015 to 2017, there were 99 recurrent cases. In total, 7.26% and 3.94% of the HZ patients had PHN and other complications, respectively. The average frequency of outpatient visits was significantly lower in patients with initial disease than that in patients with recurrence (3.6 vs. 6.7 per patient). The mean duration of hospital stay was longer in the recurrent episode than that in the initial episode (24.0 vs. 21.6 days). The inpatient and outpatient cost per new-onset HZ was approximately ¥8116.9 and ¥560.2 per patient, respectively. Age; female sex; suburban residency; and presence of immunocompromised disease, hypertension, or diabetes were significantly associated with the development of HZ.
The incidence and recurrence rates of HZ showed different trends with increasing age. The presence of HZ-related complications increased the direct medical costs. Our findings help provide a basis for developing appropriate strategies for HZ prevention and control.
带状疱疹(HZ)主要影响老年人和免疫功能低下者,其特征为疼痛性水疱性皮疹。在中国,有关 HZ 的流行病学数据,特别是在未接种疫苗的 50 岁以上人群中,仍然有限。因此,本研究旨在评估中国≥50 岁人群中 HZ 的流行病学特征、疾病负担和相关危险因素。
我们评估了 2015 年 1 月 1 日至 2017 年 12 月 31 日期间在鄞州区电子健康记录数据库中≥50 岁的 HZ 患者。使用 ICD-10 编码识别 HZ 及其并发症。此外,带状疱疹后神经痛(PHN)作为 HZ 的并发症,定义为皮疹发作后 90 天仍存在或持续疼痛。根据住院时间、就诊频率、药物治疗费用和检查费用来评估疾病负担。使用 Cox 比例风险回归来研究 HZ 的相关危险因素。
HZ 的总发病率为 6.64/1000 人年。2015 年至 2017 年期间,共发生了 4313 例初发病例,其中有 99 例复发病例。在所有 HZ 患者中,分别有 7.26%和 3.94%患有 PHN 和其他并发症。初发病例的门诊就诊频率明显低于复发病例(每位患者 3.6 次 vs. 6.7 次)。复发病例的住院时间平均长于初发病例(24.0 天 vs. 21.6 天)。每位新发 HZ 患者的住院和门诊费用分别约为 8116.9 元和 560.2 元。年龄、女性、郊区居住和存在免疫功能低下疾病、高血压或糖尿病与 HZ 的发生显著相关。
HZ 的发病率和复发率随年龄增长呈不同趋势。存在 HZ 相关并发症会增加直接医疗费用。我们的研究结果为制定 HZ 预防和控制的适当策略提供了依据。